The U.S. Food and Drug Administration on Nov. 8 approved a new oral medicine called Fruzaqla (fruquintinib) for the treatment of patients with previously treated metastatic colorectal cancer.
The U.S. Food and Drug Administration on Nov. 8 approved a new oral medicine called Fruzaqla (fruquintinib) for the treatment of patients with previously treated metastatic colorectal cancer.
Patients with metastatic colorectal cancer could find hope in new FDA-approved treatment wfin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wfin.com Daily Mail and Mail on Sunday newspapers.
Patients with metastatic colorectal cancer could find hope in new FDA-approved treatment 1010wcsi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 1010wcsi.com Daily Mail and Mail on Sunday newspapers.
A small molecule, oral targeted therapy for adults with metastatic colorectal cancer (CRC) has been approved by the US Food and Drug Administration (FDA).